MedTrace Logo

Evaluation of Efficacy and Safety of Susanna Implant in Patients With Refractory Glaucoma.

NCT01314170 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 76

Last updated 2011-05-10

No results posted yet for this study

Summary

Study clinical multicenter, phase III, open-label, prospective character to evaluate the efficacy and safety Susanna Implant in patients with refractory glaucoma.

Conditions

Interventions

DEVICE

Susanna Implant

device

Sponsors & Collaborators

  • Adapt Produtos Oftalmológicos Ltda.

    lead INDUSTRY

Principal Investigators

  • Remo Susanna, Investigator · Hospital das Clínicas de São Paulo

  • Renato Lisboa, Investigator · UNIFESP - Universidade Federal de São Paulo

  • Cláudia Galvão, Investigator · Hospital Universitário Prof. Edgar Santos - BA

  • Flávia Villas, Investigator · - Instituto brasileiro de Oftalmologia e prevenção da cegueira- BA

  • Fábio Kanadani, Investigator · Hospital Universitário São José - Belo Horizonte

  • Augusto Paranhos, Investigator · Hospital Israelita Albert Einstein

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-05-31
Primary Completion
2011-10-31
Completion
2011-10-31

Countries

  • Brazil

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01314170 on ClinicalTrials.gov